Aclarion (ACON) Net Income towards Common Stockholders (2021 - 2026)
Aclarion's (ACON) quarterly Net Income towards Common Stockholders came in at -$2.7 million in Q2 2026, down 71.64% on a YoY basis from -$9.7 million in Q2 2025, and up 3.72% quarter-over-quarter from -$2.9 million in Q1 2026.
Powered by 
Analysis
Aclarion (ACON) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Aclarion (ACON) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$2.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income towards Common Stockholders fell 71.64% year-over-year to -$2.7 million; the trailing twelve-month figure through Jun 2026 stood at -$9.2 million (down 30.26% YoY), and the FY2025 full-year result was -$7.2 million, down 2.66% from the prior year.
- Net Income towards Common Stockholders advanced to -$2.7 million in Q2 2026 per ACON's latest filing, from -$2.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$944610.0 in Q4 2022 and bottomed at -$3.7 million in Q2 2022.
- Historically, Net Income towards Common Stockholders has averaged -$1.8 million across 5 years, with a median of -$1.6 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 442.62% in 2022, then surged 60.24% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at -$944610.0 in 2022, then plunged by 33.95% to -$1.3 million in 2023, then sank by 60.99% to -$2.0 million in 2024, then grew by 7.26% to -$1.9 million in 2025, then tumbled by 45.44% to -$2.7 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$2.7 million, -$2.9 million, and -$1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn | 273.43 Mn |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn | 40.87 Mn |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn | 24.32 Mn |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn | 20.79 Mn |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn | 9.69 Mn |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn | 5.98 Mn |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn | -55.27 Mn |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn | 8.54 Mn |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn | 6.67 Mn |
| 10 | Aclarion | 5.79 Mn | 5.79 Mn | 8,297.00 | -2.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.75 Mn |
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 30, 2025 | -1.71 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -1.38 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -998,010.00 |
| Jun 30, 2023 | -1.46 Mn |
| Mar 31, 2023 | -1.18 Mn |
| Dec 31, 2022 | -944,610.00 |
| Sep 30, 2022 | -1.63 Mn |
| Jun 30, 2022 | -3.68 Mn |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | -1.30 Mn |
| Sep 30, 2021 | -3.24 Mn |